The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...

Subclade k has been circulating in Asia and in Europe, and it might already be in the United States, experts said.

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...

A new strain of the flu called subclade K could make for a particularly nasty flu season across the country, according to public health experts.  The strain already caused Japan to declare an ...

With fall here, and winter soon on the way, many parents comment how time simply flew by. Speaking of flu – ‘tis the sneezin’ ...

Health officials in Illinois are warning of a new and unexpected mutation that could make for a "more serious flu season" as ...

The new variant, known as Subclade K, is currently affecting Japan and the United Kingdom. Experts say the new variant could ...